Aramis Biotechnologies specializes in the development of novel vaccines in plants.
Aramis Biotechnologies has raised $40.0M in total funding. The most recent round was Grant. The last funding was announced in December 2024.
Aramis Biotechnologies's investors include Innovation, Science and Economic Development Canada.
Aramis Biotechnologies is headquartered in Quebec, Canada.
Aramis Biotechnologies specializes in the development of novel vaccines in plants.
Aramis Biotechnologies is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aramis Biotechnologies — Funding & Investors." VCBacked, December 5, 2024, https://www.vcbacked.co/company/aramis-biotechnologies. Accessed September 30, 2026.
VCBacked. (2024). Aramis Biotechnologies — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/aramis-biotechnologies
{{cite web |title=Aramis Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/aramis-biotechnologies |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated